Gainers
- Statera Biopharma, Inc. (NASDAQ:STAB) rose 30.4% to $0.9520 in pre-market trading. Statera Biopharma recently submitted Phase 1 clinical trial protocol to the FDA for investigational treatment of long-haul COVID-19.
- Cepton, Inc. (NASDAQ:CPTN) rose 19.7% to $9.64 in pre-market trading after dropping over 14% on Thursday.
- Funko, Inc. (NASDAQ:FNKO) rose 17.4% to $20.90 in pre-market trading after the company reported better-than-expected Q4 adjusted EPS and sales results and issued FY22 adjusted EPS guidance above analyst estimates.
- Sweetgreen, Inc. (NYSE:SG) rose 17.1% to $25.01 in pre-market trading after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates.
- iBio, Inc. (NYSE:IBIO) rose 15.4% to $0.3577 in pre-market trading after declining around 6% on Thursday.
- OceanPal Inc. (NASDAQ:OP) rose 14.6% to $0.63 in pre-market trading after gaining around 6% on Thursday.
- Veritone, Inc. (NASDAQ:VERI) rose 10.4% to $17.77 in pre-market trading after the company reported better-than-expected Q4 EPS and sales results.
- Molecular Data Inc. (NASDAQ:MKD) rose 10.4% to $0.1898 in pre-market trading after declining around 6% on Thursday.
- VEON Ltd. (NASDAQ:VEON) rose 9.5% to $0.2881 in pre-market trading after dropping 41% on Thursday.
- Hoth Therapeutics, Inc. (NASDAQ:HOTH) shares rose 9.4% to $0.66105 in pre-market trading.
- The Very Good Food Company Inc. (NASDAQ:VGFC) rose 8.7% to $0.60 in pre-market trading after gaining over 4% on Thursday.
- The Gap, Inc. (NYSE:GPS) rose 6.7% to $15.20 in pre-market trading after the company reported better-than-expected Q4 EPS and sales results.
